By REUTERS
The British drug maker has agreed to pay $105 million to settle allegations by 44 states and the District of Columbia that it promoted its medicines for unapproved uses.
Published: June 5, 2014 at 4:00AM
from NYT Business Day http://ift.tt/1i33toe
from WordPress http://ift.tt/Ud93zw
via Hadi Aboukhater
No comments:
Post a Comment